Loading...
01/10 16:25
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several negative factors: softer demand in chemical regulation, increased tax rate, revenue headwind due to a shorter quarter, and a decline in net income and EBITDA. The Q&A section highlighted concerns about utilization and regulatory delays. Despite some positive aspects like shareholder returns and interest income, the overall sentiment is negative due to financial underperformance and unclear guidance, leading to a predicted stock price decline of -2% to -8% over the next two weeks.
Total Revenues Increased 1% to $142 million year-over-year. This growth was driven by demand for dispute-related services in the construction, automotive, and medical device sectors.
Net Revenues Approximately flat at $132.9 million compared to the same period in 2024. The flat performance reflects a balance between growth in certain sectors and softer demand in others.
Net Income Decreased to $26.6 million or $0.52 per diluted share, compared to $29.2 million or $0.57 per diluted share in the prior year. The decline was influenced by a higher tax rate and reduced miscellaneous income.
EBITDA Decreased 7% to $37 million, with a margin of 27.8% of net revenues compared to 30.2% in 2024. The decrease was due to lower utilization, increased operating expenses from a Phoenix land lease renewal, and loss of a tenant at the Menlo Park facility.
Billable Hours Decreased by 6% year-over-year to approximately 359,000 hours. This was partly due to the inclusion of the July 4 holiday in the second quarter, resulting in one less day of billable activity.
Technical Full-Time Equivalent Employees Decreased by 2% year-over-year to an average of 958 employees. However, the company narrowed the headcount gap from a 5%-6% deficit at the start of the year to 2% by the end of the second quarter.
Utilization Rate Decreased to 72.1% from 75.1% in the same period of 2024. The decline was partly due to the July 4 holiday affecting billable activity.
Compensation Expense Increased by 2% after adjusting for gains and losses in deferred compensation. This includes a deferred compensation gain of $17 million compared to $875,000 in 2024.
Other Operating Expenses Increased by 8% to $12.1 million, primarily due to non-cash expenses associated with the Phoenix lease extension.
G&A Expenses Increased by 2% to $6.1 million, reflecting general administrative cost growth.
Interest Income Increased to $2.3 million, driven by higher cash and cash equivalents.
Miscellaneous Income Decreased due to the loss of a tenant at the Menlo Park facility, contributing to lower overall income.
Advanced Driver Assistance Systems: Strong activity in the automotive sector related to advanced driver assistance systems.
Medical Devices: Supported high-stakes intellectual property issues alongside product liability and safety-related matters.
Artificial Intelligence Applications: Leveraging unique capabilities in scientific user research to support clients with emerging AI applications, such as evaluating human-machine interaction in safety-critical systems.
Augmented and Virtual Reality Technologies: Advising clients on safety, reliability, and quality of immersive user experiences.
Wildfire Mitigation: Expanding work in wildfire mitigation, focusing on resilient infrastructure and risk reduction strategies.
Energy Transition: Engaged in early-stage initiatives tied to distributed energy systems and large-scale battery storage.
Headcount Growth: Narrowed technical full-time equivalent employee gap from 5%-6% to 2% by the end of Q2, with expectations of further growth in Q3 and Q4.
Recruitment Efforts: Attracting top-tier talent driven by a compelling employee value proposition and development-focused culture.
Litigation-Related Activities: Continued growth in litigation-related activities fueled by rising safety and performance expectations.
Risk Management in Utility Sector: Proactive engagements evaluating resilience of critical infrastructure and mitigating safety risks.
Flat Revenue Growth: Revenues in the second quarter were flat, indicating potential challenges in achieving significant growth in a dynamic environment.
Decreased Utilization: Utilization rates dropped to 72.1% from 75.1% year-over-year, reflecting reduced efficiency in resource usage.
Headcount Challenges: Started the year with a 5%-6% deficit in technical full-time equivalent employees, narrowing to 2% by the end of Q2, but still impacting operational capacity.
Decreased Net Income: Net income decreased to $26.6 million from $29.2 million year-over-year, signaling financial pressure.
Decreased EBITDA Margins: EBITDA margins fell to 27.8% from 30.2% year-over-year, driven by lower utilization and increased operating expenses.
Increased Operating Expenses: Operating expenses rose due to factors like the Phoenix lease renewal, adding financial strain.
Loss of Rental Income: Loss of a tenant at the Menlo Park facility reduced miscellaneous income, impacting overall financial performance.
Softer Demand in Chemical Regulation: Proactive engagements in chemical regulatory work experienced softer demand, affecting revenue streams.
Tax Rate Increase: The tax rate increased to 27.9% from 26.3% year-over-year, reducing net income.
Fourth Quarter Revenue Headwind: A 13-week fourth quarter in 2025 compared to a 14-week quarter in 2024 will result in a 6% revenue headwind.
Revenue Growth: For the third quarter of 2025, revenues before reimbursements are expected to grow in the middle single digits year-over-year. For fiscal year 2025, revenues before reimbursements are projected to grow in the low single digits.
EBITDA Margin: For the third quarter of 2025, EBITDA is expected to be 26.75% to 27.75% of revenues before reimbursements. For fiscal year 2025, EBITDA is projected to be 26.5% to 27% of revenues before reimbursements.
Headcount Growth: Year-over-year technical full-time equivalent employees are expected to increase by approximately 1% to 2% for the third quarter of 2025. By year-end, headcount is projected to be approximately 4% higher than at the start of the year.
Utilization Rate: Utilization for the third quarter of 2025 is expected to be 72% to 73%, and for the full year, it is projected to be approximately 72%.
Realized Rate Increase: The realized rate increase is expected to be 4% to 5% for both the third quarter and the full year 2025.
Stock-Based Compensation: Stock-based compensation is expected to be $5.3 million to $5.5 million for the third quarter of 2025 and $23.5 million to $24 million for the full year.
Other Operating Expenses: Other operating expenses are expected to be $12.5 million to $13 million for the third quarter of 2025 and $49.5 million to $50.5 million for the full year.
G&A Expenses: G&A expenses are expected to be $7.5 million to $8 million for the third quarter of 2025 and $24.8 million to $25.5 million for the full year.
Interest Income: Interest income is expected to be $2 million to $2.2 million per quarter for the remainder of 2025.
Miscellaneous Income: Miscellaneous income is anticipated to be approximately $200,000 per quarter for the remainder of 2025.
Tax Rate: The tax rate is expected to be approximately 28% for the third quarter of 2025 and 28.5% for the full year.
Capital Expenditures: Capital expenditures for the full year 2025 are expected to be $10 million to $12 million.
Dividend Payments: Distributed $15.2 million to shareholders through dividend payments during the quarter.
Share Repurchase: Repurchased $27.7 million of common stock at an average price of $75.66 during the quarter.
The earnings call highlights strong financial performance with increased revenues, improved utilization, and a significant realized rate increase. Shareholder returns are robust with dividends and stock repurchases. The Q&A session reveals optimism in hiring and growth, with AI integration and proactive/reactive business strategies. Despite some uncertainties in regulatory environments and rate normalization, the overall sentiment is positive, driven by strong operational metrics and strategic initiatives.
The earnings call reveals several negative factors: softer demand in chemical regulation, increased tax rate, revenue headwind due to a shorter quarter, and a decline in net income and EBITDA. The Q&A section highlighted concerns about utilization and regulatory delays. Despite some positive aspects like shareholder returns and interest income, the overall sentiment is negative due to financial underperformance and unclear guidance, leading to a predicted stock price decline of -2% to -8% over the next two weeks.
The earnings call revealed several negative factors: flat revenue and net income decline, increased tax rate, and higher stock-based compensation affecting profitability. Utilization rates are expected to decline, and there are challenges in maintaining headcount. Shareholder returns through dividends and repurchases are positive, but not enough to offset financial concerns. The Q&A session highlighted uncertainties in proactive services and unclear management responses on guidance. The market cap suggests a moderate reaction, leading to a negative stock price prediction.
The earnings call reveals flat revenue and declining net income, EPS, and EBITDA, driven by increased expenses. The Q&A highlights concerns about utilization rates and demand softness, with unclear management responses. Despite shareholder returns via dividends and buybacks, increased tax rates, supply chain challenges, and regulatory scrutiny weigh heavily. The market cap of $4.8 billion suggests a moderate reaction, leading to a negative stock price prediction of -2% to -8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
